Synthetic Polymers as Drug-Delivery Vehicles in Medicine
2008
Synthetic Polymers as Drug-Delivery Vehicles in Medicine
publication
Evidence: moderate
Author Information
Author(s): Eberhard W. Neuse
Primary Institution: School of Chemistry, University of the Witwatersrand
Hypothesis
Can polymer-drug conjugation improve the delivery and efficacy of metal-based anticancer drugs?
Conclusion
Polymer-drug conjugation has matured into a practical tool for enhancing the efficacy of metal-based anticancer drugs.
Supporting Evidence
- Polymer-drug conjugation can enhance the bioavailability of anticancer drugs.
- Polymer-bound drugs can minimize toxic side effects.
- Polymer-drug conjugates can improve drug targeting to cancer cells.
Takeaway
This study shows that using special polymers can help deliver cancer drugs more effectively, making them work better and reducing side effects.
Methodology
The study discusses the pharmacological fundamentals of polymer-drug conjugation and its application to metal-based drugs.
Limitations
The study does not provide specific experimental data or sample sizes.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website